过去一年中添加的文章,按日期排序

SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and …

JEM O'Donnell, LA Hastings, JN Briody… - Pediatric …, 2024 - Wiley Online Library
101 天前 - targets for the treatment of CFRD are the same as those in Type 1 and 2 diabetes
mellitus, 61, 62 whereby large multicentre trials have established the benefits of target HbA1c …

[HTML][HTML] Bridging the Gap: A Model for Safe Adoption of Lung SBRT in Routine Practice

CP Kirsch, J Lee, N Thawani - Cureus Journal of Medical Science, 2024 - cureus.com
138 天前 - … 130 patients with primary lung malignancies were included in this analysis to
assess … 30.77% patients showed signs of chronic grade 1 fibrosis after treatment noted on CT …

[HTML][HTML] Bioinformatics and immunoinformatics assisted multiepitope vaccine construct against Burkholderia anthina

MA Alshiekheid, AM Dou, M Algahtani… - Saudi Pharmaceutical …, 2024 - Elsevier
222 天前 - … Burkholderia anthina is a pathogenic bacterial … pulmonary diseases associated
with cystic fibrosis, due to being intrinsic antibiotic resistant making it difficult to treat pulmonary

Bivariate Mixed Effects Model with Non-stationary Stochastic Processes for Prediction of Rapid Disease Progression: Empirical Performance and Construction

Z Wang - 2023 - rave.ohiolink.edu
327 天前 - … mixed effects model utilizing integrated Brownian motion for each mean response
function. … I also propose a bivariate target function that simultaneously predicts under the two-…